* Cardio Diagnostics Holdings Inc is expected to show a rise in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2024
* The Chicago Illinois-based company is expected to report a 5,525.0% increase in revenue to $112.5 thousand from $2 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
* LSEG's mean analyst estimate for Cardio Diagnostics Holdings Inc is for a loss of 11 cents per share.
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Cardio Diagnostics Holdings Inc is $2.00, above its last closing price of $0.45.
This summary was machine generated August 9 at 22:35 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments